Answer
Yes, carfilzomib (Kyprolis) is contraindicated in people with hypersensitivity to its active substance or any excipient listed in section 6.1 of its product information.
Sources for this answer
- KyprolisAmgen Ltd · emc · SmPC §4.3 Contraindications · Version 21Document updated
Sources checked